Table 1.
Previously reported cases of recurrent perimesencephalic nonaneurysmal subarachnoid hemorrhage
Study
|
Time to recurrence
|
Potential or definite cases
|
Antithrombotic or anticoagulant or antiplatelet medication
|
Outcome
|
Marquardt et al[14], 2000 | 31 mo | Probable | None | Discharged without neurologic deficits |
Ildan et al[13], 2002 | Early rebleed | Possible | QReqse3 | Died after rebleed |
van der Worp et al[15], 2009 | 5 d | Possible | Antithrombotic for acute coronary syndrome | Died |
Reynolds et al[17], 2011 | 5 mo | Definite | Aspirin 81 mg for cardio- vascular protection, and discontinued after initial bleeding | Discharged with no neurologic deficits; complete resolution at 1 yr |
Rahme and Vyas[5], 2015 | 12 yr | Definite | None | Discharged |
Malhotra et al[16], 2016 | 8 yr | Definite | Aspirin 81 mg for myocardial infarction status post-angioplasty and stenting | Discharged Computed tomography angiography negative and no neurological deficits at 2-yr follow-up |